He studied pharmaceutical sciences at the Swiss Federal Institute of Technology in Zurich, Switzerland, and earned a PhD in pharmaceutical chemistry from the University of Basel. He joined the University of Pennsylvania, Philadelphia, USA, and the field of complement biology as a postdoctoral scientist in 2006 and turned to therapeutic aspects as an assistant and associate professor at the same institution. In 2016, he was appointed to his current position at the University of Basel. His research efforts focus on the development of therapeutic concepts for controlling adverse host defence pathway activation, including the complement system, in clinical conditions.